Clinical Toxicology
November 2, 2023
Alexandr Gish, Florian Hakim, Camille Richeval et al.
4 citations
Dear Editor,Ayahuasca is a traditional psychoactive infusion of the Amazonian indigenous people composed mainly of a mixture of Psychoteria viridis or related species (containing N,N-dimethyltrypta...
Drug Testing and Analysis
2022
Thomas Gicquel, Romain Pelletier, Camille Richeval et al.
32 citations
This work first aims to investigate metabolites of 2-fluoro-deschloroketamine (2F-DCK), a new arylcyclohexylamine derivatives (a group of dissociative ketamine-based substances) using two in vitro experimental approaches, and to compare obtained results by means of molecular networking. Metabolites of 2F-DCK were investigated using both human liver microsomes (HLMs) and hepatic (HepaRG) cell...
Forensic Science International
July 1, 2021
Thomas Gicquel, Camille Richeval, Vadim Mesli et al.
45 citations
Continuous development and rapid turnover of drug market of new psychoactive substances (NPS) make it difficult to obtain up-to-date analytical methods for efficient detection of intoxication cases with new substances: no analytical data and no previously published concentration values in biological samples are indeed available. In this context, we aim to report the first fatal case involving...
Current Pharmaceutical Design
January 30, 2018
Camille Richeval, Delphine Allorge, Xavier Vanhoye et al.
6 citations
Lysergic acid diethylamide (LSD) is a powerful hallucinogen, active at very low dosages, with, as a direct consequence, potential difficulties to be detected and quantified in a clinical or forensic context, in body fluids and even more in hair. The aim of this work is to review literature data related to hair analysis of LSD with a particular focus on the main issues encountered in LSD...
Drug Testing and Analysis
June 22, 2017
Sarah M.r. Wille, Camille Richeval, M. Nachon‐phanithavong et al.
68 citations
Driving under the influence of drugs (DUID) is a worldwide problem. Several countries have adopted DUID legislations which prove their deterrent effect and impact on road safety. However, the use of new psychoactive substances (NPS) and prescription drugs is not known, as the applied roadside screening tests have not yet been adapted for these compounds. In this study, 558 blood samples...
Drug Testing and Analysis
February 1, 2016
Yacine Boumrah, Luc Humbert, Mélodie Phanithavong et al.
One of the main challenges posed by the emergence of new psychoactive substances is their identification in human biological samples. Trying to detect the parent drug could lead to false‐negative results when the delay between consumption and sampling has been too long. The identification of their metabolites could then improve their detection window in biological matrices. Oxidative metabolism...